The 6th Neuroimmunology Drug Development Summit takes place in Boston, US on March 25-27.
As a leading provider of neurobiology in vitro research services, Cellectricon is proud to be a partner of the summit. We are very much looking forward to joining other industry experts in the discussion on approaches for discovering and developing therapies for treatment of underlying neuroinflammation in neurological disorders.
At the meeting Jonathan Levenson, CSO at FireCyte Therapeutics and scientific advisor at Cellectricon, will give a presentation on March 26:
- Outlining development of chimeric culture system where hiPSC microglia robustly respond to inflammatory stimuli
- Demonstrating functional and morphological effects of microglia-dependent inflammation using cytokine release, neuronal function and high content imaging assays
- Platform that recapitulates neuroinflammation systems biology amenable for neuroinflammatory compound screening
If you are interested in learning more about the Neuroinflammation Service Module or Cellectricon’s drug discovery services, please reach out to us.
Johan Pihl
CSO
Meet us at the Neuroimmunology drug development summit!
We are looking forward to taking part in this year’s meeting and for the opportunity to introduce our new service module for neuroinflammation research to clients and new contacts. Get in touch if you are interested in setting up a meeting!